Piriformis Syndrome Market Share by demand, revenue and forecast to 2023

20/mar/2020 19:53:35 Market Research Future Contatta l'autore

Piriformis Syndrome Market – Highlights

Piriformis Syndrome is a rare neuromuscular condition in which the piriformis muscle, located in the buttock region, spasms and causes hip and buttock pain.

The conservative treatment for piriformis syndrome includes activity modification, the use of anti-inflammatory drugs, physical therapy, an injection of local anesthetics or corticosteroids, and botulin neurotoxin injections, among others.

Major factors such as the growing occurrence of piriformis syndrome, increasing screening for neuromuscular conditions, growing success of drug treatment for the syndrome, and the growing geriatric population are expected to drive the growth of the global piriformis syndrome market.

Additionally, according to the data published by the National Center for Biotechnology Information (NCBI), in 2015, the occurrence rate of piriformis syndrome was 6% in patients with sciatica symptoms.

Piriformis Syndrome Market – Key Players

  • Bayer AG
  • Novartis AG
  • AstraZeneca
  • Endo Pharmaceuticals
  • Teva Pharmaceuticals
  • Omron Healthcare
  • Sanofi S.A.
  • DePuy Synthes Companies
  • Miracle Stretch, LLC
  • Flex Pharma, Inc.
  • Nidd valley medical
  • SEIRIN Corporation

Piriformis Syndrome Market – Regional Analysis

The global piriformis syndrome market Share consists of four regions, namely, the Americas, Europe, Asia-Pacific, and the Middle East and Africa.

The North American region holds the major share of the global piriformis syndrome market, owing to the existing well-established healthcare system, increasing secondary lifestyle, and increasing geriatric population.

Europe is anticipated to hold the second largest position in the global piriformis market owing to the growing government support for research and development activities.

Additionally, Asia-Pacific the piriformis market in Asia-Pacific consists of countries, namely, China, Japan, the Republic of Korea, India, Australia, and the rest of Asia-Pacific.

Piriformis Syndrome Market – Segmentation

The global piriformis syndrome market is segmented on the basis of cause, diagnostic test, treatment, distribution channel, and end-user. On the basis of cause, the market is classified as trauma, spasms, overuse injury, and others.

The piriformis syndrome market on the basis of diagnostic tests is segmented as Magnetic Resonance Imaging (MRI), X-ray, Computed Tomography (CT), neurophysiologic testing, Electromyography (EMG), Beatty Test, FAIR (Flexion, adduction, and Internal Rotation) test, and others.

On the basis of treatment, the market is segmented into medication, physical therapy, acupuncture, prolotherapy, Osteopathic Manipulative Treatment (OMT), surgery, and others. Medication is further segmented into NSAIDs, piriformis muscle injection, and others.

The global piriformis syndrome market, by distribution channel, is segmented into E-commerce, retail pharmacies, and others. On the basis of end-user, the global piriformis syndrome market is segmented as hospitals and clinics, diagnostic centers, and others.

BROWSE COMPLETE 100 PAGES PREMIUM RESEARCH REPORT ENABLED WITH RESPECTIVE TABLES AND FIGURES @ https://www.marketresearchfuture.com/reports/piriformis-syndrome-market-6249

Related News

Hearing Aids Market

Hepatitis B Treatment Market

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

blog comments powered by Disqus
Comunicati.net è un servizio offerto da Factotum Srl